Method for preimplantation genetic screening of embryos
OwnerClifford L. LIBRACH, Svetlana MADJUNKOVA +1inventors
InventorsClifford L. LIBRACH, Svetlana MADJUNKOVA, Valeriy KUZNYETSOV
Life of this patent
Estimating the term…
Loading patent…
OwnerClifford L. LIBRACH, Svetlana MADJUNKOVA +1inventors
InventorsClifford L. LIBRACH, Svetlana MADJUNKOVA, Valeriy KUZNYETSOV
Estimating the term…
A non-invasive method for genetic screening prior to embryo implantation is described. Fertilized oocytes are cultured on day 1 followed by removal of residual cumulus/corona cells, reducing maternal contamination; isolating oocytes and culturing individually from days 1-4 with serum protein supplement; conducting laser zona breaching on day 4 allowing embryonic cell free DNA (cfDNA) into the culture medium; washing oocytes with fresh medium to produce a medium containing day 4 cfDNA; transferring into fresh medium under oil, and culturing until day 5, 6, or 7 to form an expanded blastocyst which is transferred on day 5/6/7 into a drop of medium; exposing the expanded blastocyst to laser pulse to extrude blastocoel fluid containing embryonic cfDNA, obtaining day 5/6/7 cfDNA; and conducting genetic screening of cfDNA using whole genome amplification (WGA). The method may be used for genetic screening of embryos for aneuploidy by testing WGA for whole chromosome copy number.
A non-invasive method for genetic screening prior to implantation of an embryo, said method comprising:
(canceled)
Dependencies are inferred from the claim text.